Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,548.00
(
1.89%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
77,361.44
(
-0.14%
)
News Focus
News Focus
Post# of 9090
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122886
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jmkobers post# 4572

Tuesday, 09/26/2023 8:38:27 PM

Tuesday, September 26, 2023 8:38:27 PM

Post# of 9090
RVNC has not yet lowered the price of Daxxify to procedural parity with Botox—i.e. $110 for an on-label glabellar-lines procedure—except for practices ordering >=150 vials. So, RVNC may still have more work to do on pricing, IMO.

On the Investor Day webcast, RVNC claimed to have lowered the price of Daxxify to parity with Botox, but this is only a half-truth, as far as I can tell.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote